Top 5 Income Stocks with the Highest Upside Potential
π Bank of America lowered its price target for Becton, Dickinson and Company (BDX) from $177 to $170 on June 12.
βοΈ The analyst maintained a Neutral rating on BDX shares despite the reduction in the price target.
π₯ Lower utilization rates across the healthcare sector are driving BofA's cautious approach to 2027 medtech estimates.
π° Persistent inflation is expected to limit margin expansion for BDX and other large-cap medtech firms in 2027.
π Current stock valuations for BDX already reflect significant risks associated with utilization trends and inflation pressures.
π BDX operates globally, providing medical supplies, devices, laboratory equipment, and diagnostic products to healthcare institutions.
Risk Factors
- Bank of America reduced its price target for BDX from $177 to $170 due to concerns over lower healthcare sector utilization.
- The analyst expects inflation to remain a significant headwind in 2027, potentially limiting margin expansion for the company.
- BofA has adopted a more cautious stance on 2027 estimates for medtech companies like BDX given current valuation levels and risk factors.
Full Analysis
On June 12, Bank of America (BofA) lowered its price target for Becton, Dickinson and Company (NYSE: BDX) from $177 to $170 while maintaining a Neutral rating. The analyst cited continued lower utilization within the healthcare sector as a primary concern, leading to a more cautious outlook for 2027 estimates specifically for medtech companies.
BofA's analysis suggests that current valuations for BDX and similar peers already reflect significant risks related to utilization trends. Additionally, the firm expects inflation to persist as a major headwind in 2027, which could constrain margin expansion across the broader medical technology industry.
Consequently, Bank of America has reduced its 2027 earnings estimates for several large-cap companies in its coverage universe that face exposure to both utilization pressures and inflation. BDX is described as a global leader developing and selling medical supplies, devices, laboratory equipment, and diagnostic products used by various healthcare professionals.